Long-Term Effects of Nucleus Accumbens Deep Brain Stimulation in Treatment-Resistant Depression: Evidence for Sustained Efficacy (original) (raw)

• Bewernick BH, Hurlemann R, Matusch A, Kayser S, Grubert C, Hadrysiewicz B et al (2010). Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biol Psychiatry 67: 110–116.
  Article Google Scholar
• Cersosimo MG, Raina GB, Benarroch EE, Piedimonte F, Alemán GG, Micheli FE (2009). Micro lesion effect of the globus pallidus internus and outcome with deep brain stimulation in patients with Parkinson disease and dystonia. Mov Disord 24: 1488–1493.
  Article Google Scholar
• Coenen VA, Schlaepfer TE, Maedler B, Panksepp J (2011). Cross-species affective functions of the medial forebrain bundle-implications for the treatment of affective pain and depression in humans. Neurosci Biobehav Rev 35: 1971–1981.
  Article Google Scholar
• Denys D, Mantione M, Figee M, van den Munckhof P, Koerselman F, Westenberg H et al (2010). Deep brain stimulation of the nucleus accumbens for treatment-refractory obsessive-compulsive disorder. Arch Gen Psychiatry 67: 1061–1068.
  Article Google Scholar
• Dunner D, Rush A, Russell J, Burke M, Woodard S, Wingard P et al (2006). Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression. J Clin Psychiatry 67: 688–695.
  Article Google Scholar
• Endicott J, Cohen J, Nee J, Fleiss J, Sarantakos S (1981). Hamilton depression rating scale. Extracted from regular and change versions of the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 38: 98–103.
  Article CAS Google Scholar
• Fava M, Davidson KG (1996). Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Am 19: 179–200.
  Article CAS Google Scholar
• Granziera C, Pollo C, Russmann H, Staedler C, Ghika J, Villemure JG et al (2008). Sub-acute delayed failure of subthalamic DBS in Parkinson's disease: the role of micro-lesion effect. Parkinsonism Relat Disord 14: 109–113.
  Article CAS Google Scholar
• Grubert C, Hurlemann R, Bewernick BH, Kayser S, Hadrysiewicz B, Axmacher N et al (2011). Neuropsychological safety of nucleus accumbens deep brain stimulation for major depression: effects of 12-month stimulation. World J Biol Psychiatry 12: 516–527.
  Article Google Scholar
• Hamilton M (1967). Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6: 278–296.
  Article CAS Google Scholar
• Hamilton M (1976). HAMA Hamilton Anxiety Scale. National Institute of Mental Health: Rockville, MD.
  Google Scholar
• Hardy P (2009). [Severe depression : morbidity-mortality and suicide]. Encephale 35 (Suppl 7): S269–S271.
  Article Google Scholar
• Hautzinger M . Kognitive Verhaltenstherapie bei Depressionen. Beltz: München Weinheim; (2000).
  Google Scholar
• Holtzheimer PE, Kelley ME, Gross RE, Filkowski MM, Garlow SJ, Barrocas A et al (2012). Subcallosal cingulate deep brain stimulation for treatment-resistant unipolar and bipolar depression. Arch Gen Psychiatry 69: 150–158.
  Article Google Scholar
• Huff W, Lenartz D, Schormann M, Lee SH, Kuhn J, Koulousakis A et al (2010). Unilateral deep brain stimulation of the nucleus accumbens in patients with treatment-resistant obsessive-compulsive disorder: outcomes after one year. Clin Neurol Neurosurg 112: 137–143.
  Article Google Scholar
• Isometsa ET, Henriksson MM, Aro HM, Heikkinen ME, Kuoppasalmi KI, Lönnqvist JK (1994). Suicide in major depression. Am J Psychiatry 151: 530–536.
  Article CAS Google Scholar
• Kellner CH, Knapp RG, Petrides G, Rummans TA, Husain MM, Rasmussen K et al (2006). Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry 63: 1337–1344.
  Article Google Scholar
• Kennedy SH, Giacobbe P, Rizvi SJ, Placenza FM, Nishikawa Y, Mayberg HS et al (2011). Deep brain stimulation for treatment-resistant depression: follow-up after 3 to 6 years. Am J Psychiatry 168: 502–510.
  Article Google Scholar
• Krishnan V, Nestler EJ (2010). Linking molecules to mood: new insight into the biology of depression. Am J Psychiatry 167: 1305–1320.
  Article Google Scholar
• Lewinsohn PM, Graf M (1973). Pleasant activities and depression. J Consult Clin Psychol 41: 261–268.
  Article CAS Google Scholar
• Lozano AM, Mayberg HS, Giacobbe P, Hamani C, Craddock RC, Kennedy SH (2008). Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biol Psychiatry 64: 461–467.
  Article Google Scholar
• Malone Jr DA (2010). Use of deep brain stimulation in treatment-resistant depression. Cleveland Clinic J Med 77 (Supplement 3): S77–S80.
  Article Google Scholar
• Malone Jr DA, Dougherty DD, Rezai AR, Carpenter LL, Friehs GM, Eskandar EN et al (2009). Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biol Psychiatry 65: 267–275.
  Article Google Scholar
• Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C et al (2005). Deep brain stimulation for treatment-resistant depression. Neuron 45: 651–660.
  Article CAS Google Scholar
• McNeely HE, Mayberg HS, Lozano AM, Kennedy SH (2008). Neuropsychological impact of Cg25 deep brain stimulation for treatment-resistant depression: preliminary results over 12 months. J Nerv Ment Dis 196: 405–410.
  Article Google Scholar
• Montgomery SA, Åsberg M (1979). A new depression scale designed to be sensitive to change. Br J Psychiatry 134: 382–389.
  Article CAS Google Scholar
• Murray C, Lopez A (1996). The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 Projected to 2020. Harward University Press: Cambridge, MA.
  Google Scholar
• Nestler EJ, Carlezon Jr WA (2006). The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 59: 1151–1159.
  Article CAS Google Scholar
• Okun MS, Rodriguez RL, Mikos A, Miller K, Kellison I, Kirsch-Darrow L et al (2007). Deep brain stimulation and the role of the neuropsychologist. Clin Neuropsychol 21: 162–189.
  Article Google Scholar
• Pincus HA, Pettit AR (2001). The societal costs of chronic major depression. J Clin Psychiatry 62 (Suppl 6): 5–9.
  PubMed Google Scholar
• Rosenthal SH, Klerman GL (1966). Endogenous features of depression in women. Can Psychiatric Assoc J 11 (Suppl): 11–16.
  Google Scholar
• Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D et al (2006). Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 163: 1905–1917.
  Article Google Scholar
• Sackeim HA (2001). The definition and meaning of treatment-resistant depression. J Clin Psychiatry 62 (Suppl 16): 10–17.
  CAS Google Scholar
• Schlaepfer T, Lieb K (2005). Deep brain stimulation for treatment refractory depression. Lancet 366: 1420–1422.
  Article Google Scholar
• Schlaepfer TE, Cohen MX, Frick C, Kosel M, Brodesser D, Axmacher N et al (2008). Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropschopharmacology 33: 368–377.
  Article Google Scholar
• Spreen OS . A Compendium of Neuropsychological Tests. Oxford University Press: New York; (1991).
  Google Scholar
• Synofzik M, Fins J, Schlaepfer TE (2011). A neuromodulation experience registry for deep brain stimulation studies in psychiatric research: rationale and recommendations for implementation. Brain Stimulation, e-pub ahead of print; dx.doi.org/10.1016/j.brs.2011.10.003.
• Ware Jr JE, Sherbourne CD (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30: 473–483.
  Article Google Scholar
• Wulsin LR, Vaillant GE, Wells VE (1999). A systematic review of the mortality of depression. Psychosomatic Med 61: 6–17.
  Article CAS Google Scholar